chr9-34513112-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3PP5
The ENST00000242317.9(DNAI1):c.1490G>A(p.Gly497Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000725 in 1,613,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G497S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000242317.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1490G>A | p.Gly497Asp | missense_variant, splice_region_variant | 16/20 | ENST00000242317.9 | NP_036276.1 | |
DNAI1 | NM_001281428.2 | c.1502G>A | p.Gly501Asp | missense_variant, splice_region_variant | 16/20 | NP_001268357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.1490G>A | p.Gly497Asp | missense_variant, splice_region_variant | 16/20 | 1 | NM_012144.4 | ENSP00000242317 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251480Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135910
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461662Hom.: 0 Cov.: 31 AF XY: 0.0000825 AC XY: 60AN XY: 727164
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
ClinVar
Submissions by phenotype
Kartagener syndrome Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 11, 2018 | The DNAI1 c.1490G>A (p.Gly497Asp) variant is a missense variant that has been reported in a compound heterozygous state with a second common splice variant in one individual with primary ciliary dyskinesia (Zariwala et al. 2006). Family studies revealed that the individuals healthy father was heterozygous for the p.Gly497Asp variant, while the healthy mother was heterozygous for the splice variant. Fedick et al. (2015) also identified the p.Gly497Asp variant in a heterozygous state in three healthy Ashkenazi Jewish individuals. The p.Gly497Asp variant was absent from 211 control subjects but is reported at a frequency of 0.001117 in the Ashkenazi Jewish population of the Genome Aggregation Database. RT-PCR showed that this variant affected splicing, leading to in-frame deletion of exons 15 and 16 (Zariwala et al. 2006). Based on the limited evidence, the p.Gly497Asp variant is classified as a variant of uncertain significance but suspicious for pathogenicity for primary ciliary dyskinesia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 08, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | May 22, 2018 | - - |
Primary ciliary dyskinesia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2016 | The p.G497D pathogenic mutation (also known as c.1490G>A) is located in coding exon 16 of the DNAI1 gene. The glycine at codon 497 is replaced by aspartic acid, an amino acid with similar properties. This change occurs in the first base pair of coding exon 16. This mutation was detected in a patient with primary ciliary dyskinesia who was compound heterozygous for another DNAI mutation. The two mutations were confirmed through family studies to be in trans. Parental RNA analysis revealed an aberrant splice product from the p.G497D allele, leading to an in-frame deletion of 56 amino acids due to skipping of exons 15 and 16 (Zariwala MA, Am. J. Respir. Crit. Care Med. 2006 Oct; 174(8):858-66). Based on the supporting evidence, p.G497D is interpreted as a disease-causing mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 497 of the DNAI1 protein (p.Gly497Asp). RNA analysis indicates that this missense change induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs376252276, gnomAD 0.1%). This missense change has been observed in individual(s) with primary ciliary dyskinesia (PMID: 16858015). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 65703). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Studies have shown that this missense change results in skipping of exons 15-16, but is expected to preserve the integrity of the reading-frame (PMID: 16858015). For these reasons, this variant has been classified as Pathogenic. - |
DNAI1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 01, 2023 | The DNAI1 c.1490G>A variant is predicted to result in the amino acid substitution p.Gly497Asp. This variant was reported in the compound heterozygous state, along with the pathogenic c.48+2dup variant, in an individual with primary ciliary dyskinesia (Zariwala et al. 2006. PubMed ID: 16858015). mRNA studies showed that this variant causes the skipping of exons 15 and 16 and results in an in-frame deletion of 56 amino acids (R468_K523del) (Zariwala et al. 2006. PubMed ID: 16858015). This variant is reported in 0.13% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/9-34513110-G-A). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at